• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

TLC plans to emerge from bankruptcy as private company

Article

TLC Vision Corp. and two of its wholly owned subsidiaries, TLC Vision (USA) Corp. and TLC Management Services, are restructuring their debt through a pre-arranged Chapter 11 bankruptcy proceeding.

St. Louis, MO

-TLC Vision Corp. and two of its wholly owned subsidiaries, TLC Vision (USA) Corp. and TLC Management Services, are restructuring their debt through a pre-arranged Chapter 11 bankruptcy proceeding. As part of its plans, the company has secured $15 million in financing and will sell six refractive centers in Canada.

Operations elsewhere are continuing. TLC Laser Eye Centers are not part of the filing. The company said it expects to emerge from bankruptcy as a private company.

“After evaluating a number of strategic alternatives with our board of directors and advisers, we decided that restructuring our debt through court protection was the best way to preserve the value of our business,” said Jim Tiffany, TLC Vision president and chief executive officer. “We expect to emerge swiftly from Chapter 11 with a stronger balance sheet and able to better capitalize on our industry leadership position.”

Court documents are accessible at

http://chapter11.epiqsystems.com/tlcvision

. The company also has establishing hotlines: 877/879-5075 for callers from the United States and Canada and 503/597-7713 for international callers.

Related Videos
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
Lorraine Provencher, MD, presenting slides
Katherine Talcott, MD, presenting slides
Katherine Talcott, MD, presenting slides
© 2024 MJH Life Sciences

All rights reserved.